Close

Form 6-K GLAXOSMITHKLINE PLC For: Feb 11

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. BA
5. SPOT
6. META
7. V
8. IBM
9. KMB
10. HCP


February 11, 2015 9:52 AM EST

FORM 6-K/A
�
�
SECURITIES AND EXCHANGE COMMISSION(
Washington D.C. 20549
�
�
Report of Foreign Issuer
�
�
Pursuant to Rule 13a-16 or 15d-16 of(
athe Securities Exchange Act of 1934
�
�
�
For period ending�February 2015
�
GlaxoSmithKline plc
(Name of registrant)(

�
�
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)(

�
�
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F(

�
�
Form 20-F x��� �Form 40-F(
�
--(
�
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.(

�
�
Yes����� No x
--
�
�

��������������������������������������������������������������������������������������������� GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4R(1)(a) and (c) GlaxoSmithKline plc ('GSK') was advised on 11 February 2015 that the following Directors, Persons Discharging Managerial Responsibilities and Connected Person acquired GSK Ordinary Shares ('Shares') on 10 February 2015, at a price of 1505.46 pence per Ordinary Share, through GSK's Share Reward Plan (the 'Plan'):
�
Director/PDMR
Number of Shares under the personal contribution element of the plan
Number of Shares under the matching element of the plan
(GSK contribution)
Sir Andrew Witty
8
8
Mr R G Connor
8
8
Mr S Dingemans
8
8
Mr N Hirons
8
8
Mr D S Redfern
8
8
Ms C Thomas
8
8
Mr P C Thomson
8
8
Dr P J T Vallance
9
9
Ms E Walmsley
8
8
Mrs V A Whyte
8
8
� � �

�
Connected person
Number of Shares under the personal contribution element of the plan
Number of Shares under the matching element of the plan
(GSK contribution)
Mrs K Thomson (Connected person of Mr P C Thomson)
4
4

V A Whyte
Company Secretary
11 February 2015
�

�







�
��
SIGNATURES
�
�
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.(


�
�
GlaxoSmithKline plc
(Registrant)(

Date:�February 11,�2015�
�
�
By:�VICTORIA WHYTE
----------------------
�
�
Victoria�Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings